Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q1

8129.TEDINET S100OXRX
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥323.4bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥1.27T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥308.8bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥635m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥3.1bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥18.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥3.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥2.4bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.7bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥1.7bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥710.1bnat 2022-06-30Cons.Assets
Total assets¥702.4bnat 2022-03-31Cons.Assets
Total assets¥697.5bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥466.3bnat 2022-06-30Cons.Liabilities
Total liabilities¥461.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥243.7bnat 2022-06-30Cons.Net assets
Net assets / equity¥241.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥237.4bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥94.4bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥94.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥29.222022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥189.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥24.552021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥26.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥174.482021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥22.552021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio34.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.0%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥401m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥133m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-06-30¥612m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-06-30¥288m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-06-30¥311.8bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-06-30¥299.4bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥356m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥94m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥338.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥323.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥14.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥14.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥14.5bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥466m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2021-04-01 → 2021-06-30¥22.5bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2021-04-01 → 2021-06-30¥22.5bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2021-04-01 → 2021-06-30¥350m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2021-04-01 → 2021-06-30¥403m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2021-04-01 → 2021-06-30¥195m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2021-04-01 → 2021-06-30¥297.6bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2021-04-01 → 2021-06-30¥284.9bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2021-04-01 → 2021-06-30¥554m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥1.3bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥966m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥305m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥0
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥323.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥308.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥14.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 420
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member7717800
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0986
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row2Member33000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row2Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row2Member33000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row2Member0.0004
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row3Member1000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row3Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row3Member1000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row3Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant7751800
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant7751800
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0990
Cash and depositsPrior1YearInstant94256000000JPY
Cash and depositsCurrentQuarterInstant94385000000JPY
Notes and accounts receivable tradePrior1YearInstant301601000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant306361000000JPY
Merchandise and finished goodsPrior1YearInstant80169000000JPY
Merchandise and finished goodsCurrentQuarterInstant80987000000JPY
Raw materials and suppliesPrior1YearInstant194000000JPY
Raw materials and suppliesCurrentQuarterInstant175000000JPY
Other caPrior1YearInstant37175000000JPY
Other caCurrentQuarterInstant38310000000JPY
Allowance for doubtful accounts caPrior1YearInstant-290000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-292000000JPY
Current assetsPrior1YearInstant513107000000JPY
Current assetsCurrentQuarterInstant519927000000JPY
Property plant and equipmentPrior1YearInstant94653000000JPY
Property plant and equipmentCurrentQuarterInstant93625000000JPY
GoodwillPrior1YearInstant733000000JPY
GoodwillCurrentQuarterInstant717000000JPY
Other iaPrior1YearInstant4443000000JPY
Other iaCurrentQuarterInstant4515000000JPY
Intangible assetsPrior1YearInstant5177000000JPY
Intangible assetsCurrentQuarterInstant5233000000JPY
Investment securitiesPrior1YearInstant78742000000JPY
Investment securitiesCurrentQuarterInstant80486000000JPY
Other ioaPrior1YearInstant12547000000JPY
Other ioaCurrentQuarterInstant12546000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-1851000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-1760000000JPY
Investments and other assetsPrior1YearInstant89438000000JPY
Investments and other assetsCurrentQuarterInstant91271000000JPY
Noncurrent assetsPrior1YearInstant189268000000JPY
Noncurrent assetsCurrentQuarterInstant190130000000JPY
AssetsPrior1YearInstant702376000000JPY
AssetsCurrentQuarterInstant710058000000JPY
Notes and accounts payable tradePrior1YearInstant370012000000JPY
Notes and accounts payable tradeCurrentQuarterInstant377029000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass